指南与共识乳腺MR乳腺X线US

高于平均风险女性的乳腺癌筛查:ACR更新建议

Breast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR.
指南 / 共识 · J Am Coll Radiol · 2023-05-05

美国放射学会(ACR)更新了高于平均风险女性的乳腺癌筛查建议:多数高风险女性首选乳腺MRI补充筛查;遗传性高风险、终生风险≥20%或年轻时胸部放疗者建议25-30岁起MRI监测并每年乳腺X线摄影(起始年龄25-40岁视风险类型而定);突变携带者如按建议每年乳腺MRI筛查,乳腺X线摄影可延迟至40岁;50岁前确诊乳腺癌或乳腺癌个人史伴致密乳腺者应每年补充乳腺MRI;其他个人史或活检不典型增生者强烈考虑MRI筛查;致密乳腺希望补充筛查者推荐MRI,无法MRI者可考虑对比增强乳腺X线摄影或超声;所有女性应在25岁前完成风险评估。

要点

  • 多数高于平均风险女性补充筛查首选乳腺MRI。
  • 遗传性高风险、终生风险≥20%或年轻胸部放疗者,25-30岁起MRI监测并每年乳腺X线摄影。
  • 突变携带者如每年乳腺MRI筛查,乳腺X线摄影可延迟至40岁。

核心结论

  • ACR更新建议:多数高于平均风险女性补充筛查首选乳腺MRI;遗传性高风险、终生风险≥20%或年轻胸部放疗者建议25-30岁起MRI监测并每年乳腺X线摄影;突变携带者如按建议每年乳腺MRI筛查,乳腺X线摄影可延迟至40岁;50岁前确诊乳腺癌或乳腺癌个人史伴致密乳腺者应每年补充乳腺MRI;其他个人史或活检不典型增生者强烈考虑MRI筛查;致密乳腺希望补充筛查者推荐MRI,无法MRI者可考虑对比增强乳腺X线摄影或超声;所有女性应在25岁前完成风险评估。

研究设计与样本

  • 美国放射学会(ACR)更新的建议文件;未报告系统检索方法、证据分级及样本量。

诊断标准与关键数值

  • 遗传性高风险、终生风险≥20%或年轻时胸部放疗者:建议25-30岁起MRI监测并每年乳腺X线摄影,乳腺X线摄影起始年龄25-40岁视风险类型而定。
  • 突变携带者:如按建议每年乳腺MRI筛查,乳腺X线摄影可延迟至40岁。
  • 50岁前确诊乳腺癌或乳腺癌个人史伴致密乳腺者:应每年补充乳腺MRI。
  • 其他个人史或活检不典型增生者:强烈考虑MRI筛查,尤其存在其他风险因素时。
  • 致密乳腺希望补充筛查者:推荐乳腺MRI;无法MRI者可考虑对比增强乳腺X线摄影或超声。

临床应用与阅片要点

  • 所有女性应在25岁前完成风险评估,尤其黑人女性和德系犹太人后裔,以识别高于平均风险者并启动适当筛查。
  • 多数高于平均风险女性补充筛查首选乳腺MRI。
  • 无法接受乳腺MRI者可考虑对比增强乳腺X线摄影或超声。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Early detection decreases breast cancer death. The ACR recommends annual screening beginning at age 40 for women of average risk and earlier and/or more intensive screening for women at higher-than-average risk. For most women at higher-than-average risk, the supplemental screening method of choice is breast MRI. Women with genetics-based increased risk, those with a calculated lifetime risk of 20% or more, and those exposed to chest radiation at young ages are recommended to undergo MRI surveillance starting at ages 25 to 30 and annual mammography (with a variable starting age between 25 and 40, depending on the type of risk). Mutation carriers can delay mammographic screening until age 40 if annual screening breast MRI is performed as recommended. Women diagnosed with breast cancer before age 50 or with personal histories of breast cancer and dense breasts should undergo annual supplemental breast MRI. Others with personal histories, and those with atypia at biopsy, should strongly consider MRI screening, especially if other risk factors are present. For women with dense breasts who desire supplemental screening, breast MRI is recommended. For those who qualify for but cannot undergo breast MRI, contrast-enhanced mammography or ultrasound could be considered. All women should undergo risk assessment by age 25, especially Black women and women of Ashkenazi Jewish heritage, so that those at higher-than-average risk can be identified and appropriate screening initiated.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Monticciolo, Newell, Moy, et al. Breast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR. J Am Coll Radiol. 2023. PMID: 37150275. doi:10.1016/j.jacr.2023.04.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。